Potential Nutrient Deficiencies : Semaglutide can reduce appetite, which may lead to lower intake of essential nutrients like iron, vitamin B12, and folate
Detailed TRIUMPH-1 data is expected to be presented at the 86th American Diabetes Association Scientific Sessions later in 2026
We also offer lab testing to monitor hormone health, blood sugar, and metabolic changes
FRIDAY, June 6, 2025 (HealthDay News) -- For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular degeneration (nAMD) development, according to a study published online June 5 in JAMA Ophthalmology.Reut Shor, M.D., from the University of Toronto in Canada, and colleagues examined the risk for developing nAMD associated with GLP-1 RA use in patients with diabetes in a population-based, retrospective cohort study
Allocati N, Masulli M, Di Ilio C, Federici L (2018) Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
And when researchers combine them, the result is a metabolic environment where fat breaks down faster while appetite drops simultaneously